A combination of ß-hydroxybutyrate and citrate ameliorates disease progression in a rat model of polycystic kidney disease.

Our research has shown that interventions producing a state of ketosis are highly effective in rat, mouse, and cat models of polycystic kidney disease (PKD), preventing and partially reversing cyst growth and disease progression. The ketone ß-hydroxybutyrate (BHB) appears to underlie this effect. In addition, we have demonstrated that naturally formed microcrystals within kidney tubules trigger a renoprotective response that facilitates tubular obstruction clearance in healthy animals but, alternatively, leads to cyst formation in PKD. The administration of citrate prevents microcrystal formation and slows PKD progression. Juvenile Cy/+ rats, a nonorthologous PKD model, were supplemented from 3 to 8 wk of age with water containing titrated BHB, citrate, or in combination to find minimal effective and optimal dosages, respectively. Adult rats were given a reduced BHB/citrate combination or equimolar control K/NaCl salts from 8 to 12 wk of age. In addition, adult rats were placed in metabolic cages following BHB, citrate, and BHB/citrate administration to determine the impact on mineral, creatinine, and citrate excretion. BHB or citrate alone effectively ameliorates disease progression in juvenile rats, decreasing markers of cystic disease and, in combination, producing a synergistic effect. BHB/citrate leads to partial disease regression in adult rats with established cystic disease, inhibiting cyst formation and kidney injury. BHB/citrate confers benefits via multiple mechanisms, increases creatinine and citrate excretion, and normalizes mineral excretion. BHB and citrate are widely available and generally recognized as safe compounds and, in combination, exhibit high promise for supporting kidney health in polycystic kidney disease.NEW & NOTEWORTHY Combining ß-hydroxybutyrate (BHB) and citrate effectively slows and prevents cyst formation and expansion in young Cy/+ rats using less BHB and citrate than when used alone, demonstrating synergy. In adult rats, the combination causes a partial reversal of existing disease, reducing cyst number and cystic area, preserving glomerular health, and decreasing markers of kidney injury. Our results suggest a safe and feasible strategy for supporting kidney health in polycystic kidney disease (PKD) using a combination of BHB and citrate.

A simple route to functionalized porous carbon foams from carbon nanodots for metal-free pseudocapacitors.

The development of potent pseudocapacitive charge storage materials has emerged as an effective solution for closing the gap between high-energy density batteries and high-power density and long-lasting electrical double-layer capacitors. Sulfonyl compounds are ideal candidates owing to their rapid and reversible redox reactions. However, structural instability and low electrical conductivity hinder their practical application as electrode materials. This work addresses these challenges using a fast and clean laser process to interconnect sulfonated carbon nanodots into functionalized porous carbon frameworks. In this bottom-up approach, the resulting laser-converted three-dimensional (3D) turbostratic carbon foams serve as high-surface-area, conductive scaffolds for redox-active sulfonyl groups. This design enables efficient faradaic processes using pendant sulfonyl groups, leading to a high specific capacitance of 157.6 F g-1 due to the fast reversible redox reactions of sulfonyl moieties. Even at 20 A g-1, the capacitance remained at 78.4% due to the uniform distribution of redox-active sites on the graphitic domains. Additionally, the 3D-tsSC300 electrode showed remarkable cycling stability of >15 000 cycles. The dominant capacitive processes and kinetics were analysed using extensive electrochemical characterizations. Furthermore, we successfully used 3D-tsSC300 in flexible solid-state supercapacitors, achieving a high specific capacitance of up to 17.4 mF cm-2 and retaining 91.6% of the initial capacitance after 20 000 cycles of charge and discharge coupled with 90° bending tests. Additionally, an as-assembled flexible all-solid-state symmetric supercapacitor exhibits a high energy density of 12.6 mW h cm-3 at a high power density of 766.2 W cm-3, both normalized by the volumes of the full device, which is comparable or better than state-of-the-art commercial pseudocapacitors and hybrid capacitors. The integrated supercapacitor provides a wide potential window of 2.0 V using a serial circuit, showing great promise for metal-free energy storage devices.

ß-hydroxybutyrate recapitulates the beneficial effects of ketogenic metabolic therapy in polycystic kidney disease.

Autosomal-dominant polycystic kidney disease (ADPKD) is a common monogenic disease characterized by the formation of fluid-filled renal cysts, loss of mitochondrial function, decreased fatty acid oxidation, increased glycolysis, and likely renal failure. We previously demonstrated that inducing a state of ketosis ameliorates or reverses PKD progression in multiple animal models. In this study, we compare time-restricted feeding and 48-h periodic fasting regimens in both juvenile and adult Cy/+ rats. Both fasting regimens potently prevent juvenile disease progression and partially reverse PKD in adults. To explore the mechanism of fasting, we administered ß-hydroxybutyrate (BHB) to Cy/+ rats and orthologous mouse models of PKD (Pkd1 RC/RC , Pkd1-Ksp:Cre). BHB recapitulated the effects of fasting in these models independent of stereoisomer, suggesting the effects of BHB are largely due to its signaling functions. These findings implicate the use of ketogenic metabolic therapy and BHB supplementation as potential disease modifiers of PKD and point toward underlying mechanisms.